149 related articles for article (PubMed ID: 23970096)
1. Mutation of TGF-β receptor II facilitates human bladder cancer progression through altered TGF-β1 signaling pathway.
Bian J; Li B; Zeng X; Hu H; Hong Y; Ouyang H; Zhang X; Wang Z; Zhu H; Lei P; Huang B; Shen G
Int J Oncol; 2013 Nov; 43(5):1549-59. PubMed ID: 23970096
[TBL] [Abstract][Full Text] [Related]
2. Role of dihydrotestosterone (DHT) on TGF-β1 signaling pathway in epithelial ovarian cancer cells.
Kohan-Ivani K; Gabler F; Selman A; Vega M; Romero C
J Cancer Res Clin Oncol; 2016 Jan; 142(1):47-58. PubMed ID: 26091707
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of TGF-beta receptor I by siRNA suppresses the motility and invasiveness of T24 bladder cancer cells via modulation of integrins and matrix metalloproteinase.
Li Y; Yang K; Mao Q; Zheng X; Kong D; Xie L
Int Urol Nephrol; 2010 Jun; 42(2):315-23. PubMed ID: 19669587
[TBL] [Abstract][Full Text] [Related]
4. Absence of transforming growth factor-beta type II receptor is associated with poorer prognosis in HER2-negative breast tumours.
Paiva CE; Drigo SA; Rosa FE; Moraes Neto FA; Caldeira JRF; Soares FA; Domingues MAC; Rogatto SR
Ann Oncol; 2010 Apr; 21(4):734-740. PubMed ID: 19914962
[TBL] [Abstract][Full Text] [Related]
5. GP73 promotes invasion and metastasis of bladder cancer by regulating the epithelial-mesenchymal transition through the TGF-β1/Smad2 signalling pathway.
Yang HJ; Liu GL; Liu B; Liu T
J Cell Mol Med; 2018 Mar; 22(3):1650-1665. PubMed ID: 29349903
[TBL] [Abstract][Full Text] [Related]
6. The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer.
Yamamura S; Matsumura N; Mandai M; Huang Z; Oura T; Baba T; Hamanishi J; Yamaguchi K; Kang HS; Okamoto T; Abiko K; Mori S; Murphy SK; Konishi I
Int J Cancer; 2012 Jan; 130(1):20-8. PubMed ID: 21503873
[TBL] [Abstract][Full Text] [Related]
7. PKCalpha-induced drug resistance in pancreatic cancer cells is associated with transforming growth factor-beta1.
Chen Y; Yu G; Yu D; Zhu M
J Exp Clin Cancer Res; 2010 Aug; 29(1):104. PubMed ID: 20684793
[TBL] [Abstract][Full Text] [Related]
8. GDF-15 inhibits integrin activation and mouse neutrophil recruitment through the ALK-5/TGF-βRII heterodimer.
Artz A; Butz S; Vestweber D
Blood; 2016 Jul; 128(4):529-41. PubMed ID: 27235139
[TBL] [Abstract][Full Text] [Related]
9. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
Fanayan S; Firth SM; Baxter RC
J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
[TBL] [Abstract][Full Text] [Related]
10. Dual role of TGFBR3 in bladder cancer.
Liu XL; Xiao K; Xue B; Yang D; Lei Z; Shan Y; Zhang HT
Oncol Rep; 2013 Sep; 30(3):1301-8. PubMed ID: 23835618
[TBL] [Abstract][Full Text] [Related]
11. TGF-β1 promotes the migration and invasion of bladder carcinoma cells by increasing fascin1 expression.
Zhang N; Bi X; Zeng Y; Zhu Y; Zhang Z; Liu Y; Wang J; Li X; Bi J; Kong C
Oncol Rep; 2016 Aug; 36(2):977-83. PubMed ID: 27350089
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of transforming growth factor-β1 suppress Pokemon/epithelial-mesenchymal transition expression in human bladder cancer cells.
Li W; Kidiyoor A; Hu Y; Guo C; Liu M; Yao X; Zhang Y; Peng B; Zheng J
Tumour Biol; 2015 Feb; 36(2):1155-62. PubMed ID: 25722217
[TBL] [Abstract][Full Text] [Related]
13. Effect of the abrogation of TGF-beta1 by antisense oligonucleotides on the expression of TGF-beta-isoforms and their receptors I and II in isolated fibroblasts from keloid scars.
Bran GM; Goessler UR; Schardt C; Hormann K; Riedel F; Sadick H
Int J Mol Med; 2010 Jun; 25(6):915-21. PubMed ID: 20428796
[TBL] [Abstract][Full Text] [Related]
14. Augmenter of liver regeneration inhibits TGF-β1-induced renal tubular epithelial-to-mesenchymal transition via suppressing TβR II expression in vitro.
Liao XH; Zhang L; Chen GT; Yan RY; Sun H; Guo H; Liu Q
Exp Cell Res; 2014 Oct; 327(2):287-96. PubMed ID: 25092350
[TBL] [Abstract][Full Text] [Related]
15. Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins.
Morrell NW; Yang X; Upton PD; Jourdan KB; Morgan N; Sheares KK; Trembath RC
Circulation; 2001 Aug; 104(7):790-5. PubMed ID: 11502704
[TBL] [Abstract][Full Text] [Related]
16. Increased pSmad2 expression and cytoplasmic predominant presence of TGF-βRII in breast cancer tissue are associated with poor prognosis: results from the Shanghai Breast Cancer Study.
Qiu Q; Su Y; Zheng Y; Cai H; Wu S; Lu W; Zheng W; Shu XO; Cai Q
Breast Cancer Res Treat; 2015 Jan; 149(2):467-77. PubMed ID: 25542272
[TBL] [Abstract][Full Text] [Related]
17. Conditional ablation of TGF-β signaling inhibits tumor progression and invasion in an induced mouse bladder cancer model.
Liang Y; Zhu F; Zhang H; Chen D; Zhang X; Gao Q; Li Y
Sci Rep; 2016 Jul; 6():29479. PubMed ID: 27378170
[TBL] [Abstract][Full Text] [Related]
18. Induction of TGF-β1 synthesis by macrophages in response to apoptotic cells requires activation of the scavenger receptor CD36.
Xiong W; Frasch SC; Thomas SM; Bratton DL; Henson PM
PLoS One; 2013; 8(8):e72772. PubMed ID: 23936544
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor.
Fanayan S; Firth SM; Butt AJ; Baxter RC
J Biol Chem; 2000 Dec; 275(50):39146-51. PubMed ID: 10993898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
